ATE313799T1 - Nachweis von hla-g - Google Patents

Nachweis von hla-g

Info

Publication number
ATE313799T1
ATE313799T1 AT00963825T AT00963825T ATE313799T1 AT E313799 T1 ATE313799 T1 AT E313799T1 AT 00963825 T AT00963825 T AT 00963825T AT 00963825 T AT00963825 T AT 00963825T AT E313799 T1 ATE313799 T1 AT E313799T1
Authority
AT
Austria
Prior art keywords
hla
antibodies
disclosed
detection
bind
Prior art date
Application number
AT00963825T
Other languages
English (en)
Inventor
Clifford L Librach
Shang-Mian Yie
Original Assignee
Clifford L Librach
Shang-Mian Yie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clifford L Librach, Shang-Mian Yie filed Critical Clifford L Librach
Application granted granted Critical
Publication of ATE313799T1 publication Critical patent/ATE313799T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/906—Fertility tests
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Organic Insulating Materials (AREA)
AT00963825T 1999-09-27 2000-09-27 Nachweis von hla-g ATE313799T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40705699A 1999-09-27 1999-09-27
PCT/CA2000/001116 WO2001023893A2 (en) 1999-09-27 2000-09-27 Detection of hla-g

Publications (1)

Publication Number Publication Date
ATE313799T1 true ATE313799T1 (de) 2006-01-15

Family

ID=23610425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00963825T ATE313799T1 (de) 1999-09-27 2000-09-27 Nachweis von hla-g

Country Status (7)

Country Link
US (1) US6613538B2 (de)
EP (1) EP1224465B1 (de)
AT (1) ATE313799T1 (de)
AU (1) AU780825B2 (de)
CA (1) CA2386066C (de)
DE (1) DE60025022D1 (de)
WO (1) WO2001023893A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126829A1 (en) * 2001-12-18 2004-07-01 Hildebrand William H. Anti-HLA assay and methods
WO2005022149A1 (en) * 2003-08-28 2005-03-10 Coopersurgical, Inc. Method for determining embryo quality
US20050241013A1 (en) * 2004-04-22 2005-10-27 Geoffrey Sher Unique use of sHLA-G obtained in soluble form from JEG-3 cell line, by purification by PCR, HPLC, or any other techniques, as well as in other forms, as an implantation promoting agent when added to embryo culture and/or to the media in which embryos are transferred to the uterus following in vitro fertilization
WO2007089734A2 (en) * 2006-01-27 2007-08-09 Eastern Virginia Medical School Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential
ATE454632T1 (de) 2006-04-20 2010-01-15 Northern Sydney And Central Co Verfahren zur beurteilung der lebensfähigkeit von embryos
US20120196285A1 (en) * 2011-01-31 2012-08-02 Esoterix Genetic Laboratories, Llc Methods for Enriching Microparticles or Nucleic Acids Using Binding Molecules
EP3274715A4 (de) * 2015-03-27 2018-10-10 University of Southern California Hla-g als neuartiges target der car-t-zell-immuntherapie
ES2904573T3 (es) 2015-03-27 2022-04-05 Univ Southern California Terapia con células T dirigida a LHR para el tratamiento de tumores sólidos
CN113045656B (zh) * 2020-07-27 2022-03-08 台州恩泽医疗中心(集团) 抗hla-g异构体分子hla-g5及hla-g6的单克隆抗体及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11503320A (ja) * 1995-04-07 1999-03-26 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｈｌａ−ｇ検出用抗体
EP1056886A1 (de) * 1998-02-25 2000-12-06 National University of Ireland, Cork Hla-verbundene pre-eclampsia und fehlgeburt empfindlichkeitsgen
EP1131632A2 (de) * 1998-11-16 2001-09-12 Umedik, Inc. Vorrichtung und verfahren zur analyse einer biologischen probe

Also Published As

Publication number Publication date
WO2001023893A2 (en) 2001-04-05
CA2386066A1 (en) 2001-04-05
WO2001023893A3 (en) 2001-05-17
AU7500600A (en) 2001-04-30
EP1224465A2 (de) 2002-07-24
AU780825B2 (en) 2005-04-21
EP1224465B1 (de) 2005-12-21
US6613538B2 (en) 2003-09-02
CA2386066C (en) 2004-12-21
DE60025022D1 (de) 2006-01-26
US20020015973A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
HUP0202532A2 (hu) Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása
PT1190257E (pt) Deteccao precoce dos flavivirus, utilizando a glicoproteina ns1
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
EP2305715A3 (de) Monoklonaler Antikörper gegen das Osteoprotegerin-bindenden Protein
WO2002020569A3 (en) Mammalian genes; related reagents and methods
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
DK1692181T3 (da) Leptinantagonist og fremgangsmåde til kvantitativ måling af leptin
ATE313799T1 (de) Nachweis von hla-g
ATE430939T1 (de) Schwangerschaftsnachweisverfahren
EP2365002A3 (de) Zusammensetzung zur Behandlung einer Krankheit, die mit MSRV/HERV-W assoziiert ist
EP1433792A8 (de) Menschlische-rezeptor Proteine; verwandte Reagenzien und Methoden
BR9709958A (pt) Polipeptídeos capaz de formar estruturas de ligaçãode antígeno com especificidade para os antígenos de rhesus d o dna que os codifica e o processo para sua preparação e uso
WO2001061305A3 (en) Immunoassays detecting or making use of at least two rubber latexallergens
IL157047A0 (en) Methods and devices for quantitation of glycated protein
WO1999046379A3 (en) Human receptor proteins; related reagents and methods
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
WO2002090989A3 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE229651T1 (de) Rezeptorbindungsassays und reagenziensatz zum nachweis von tsh-rezeptor-autoantikörpern
WO2000039154A8 (de) Peptide des at1-rezeptors und ihre verwendung bei präeklampsie und maligner hypertonie
DE602004029589D1 (de) Testverfahren zur bestimmung von analyten mittels analytanalogen
Fox Measurement of streptococcal antigen synthesis with fluorescent antibody.
MXPA02011906A (es) Ensayo, equipo y procedimiento a base de esferas no lavables.
AU2001294565A1 (en) In vitro assay for measuring the immunogenicity of a vaccine
WO2005108427A3 (de) Verfahren zur herstellung löslicher mhc-proteine
AU2001295423A1 (en) Indirect method for the quantitative analysis of the binding capacity present in an aqueous protein solution

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties